Trial Profile
Adjuvant Therapy With Thalidomide After Curative Resection of Hepatocellular Carcinoma.: a Randomized Controlled Trial
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 15 Jan 2024
Price :
$35
*
At a glance
- Drugs Thalidomide (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 17 Sep 2013 New trial record